Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose vs Iron Sucrose in Non-dialysis CKD
NCT06994065Completed
- Sponsor
- Sindh Institute of Urology and Transplantation
- Start
- Apr 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Sindh Institute of Urology and Transplantation. Primary endpoints: Change from baseline in hemoglobin concentration at Day 56, Change from baseline in Transferrin Saturation at Day 56 and 1 more. Started Apr 2025; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06994065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06994065.